Hospital
Brandon Hma LLC
Brandon Hma LLC was paid $10.08M by Medicaid between Jan 2018 and Dec 2024, across 131 billing codes. Its largest line is 99283, emergency room visit (moderate) — 27% of everything it billed.
33Billing provider infoBRANDON HMA LLC
BRANDON, MS 39042
BRANDON, MS 39042
33aNPI1205882669assigned 05/26/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$10.08M
24GClaims253,005
24DCodes billed131
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Mississippi
Rank by total paid#35 of 77
Median peer was paid$8.23M
This provider vs. median1.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 40,975 | $1.90M | |
| 2019 | 34,928 | $1.47M | |
| 2020 | 27,960 | $1.01M | |
| 2021 | 36,584 | $1.29M | |
| 2022 | 49,394 | $1.64M | |
| 2023 | 42,200 | $1.45M | |
| 2024incomplete | 20,964 | $1.32M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 27% | 21,072 | 16,328 | $2.68M |
| D7140 | Extraction, erupted tooth or exposed root | 15% | 3,746 | 1,161 | $1.50M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 12% | 7,664 | 5,895 | $1.23M |
| D2930 | Prefabricated stainless steel crown - primary tooth | 7.4% | 9,282 | 1,882 | $747K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.7% | 5,854 | 4,675 | $470K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.6% | 1,915 | 1,514 | $365K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.9% | 3,876 | 2,904 | $293K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.6% | 7,776 | 5,676 | $261K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2.1% | 4,558 | 3,677 | $211K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.0% | 5,380 | 4,504 | $202K |
| 71045 | Radiologic examination, chest; single view | 2.0% | 5,989 | 4,562 | $199K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.6% | 1,679 | 1,265 | $159K |
119 more codes
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | 1.3% | 2,517 | $135K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.1% | 5,281 | $109K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,238 | $100K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 2,026 | $98K |
| 87428 | <1% | 2,179 | $97K | |
| 87430 | <1% | 8,322 | $97K | |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 2,484 | $93K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 5,892 | $91K |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 946 | $75K |
| 87276 | <1% | 6,535 | $73K | |
| G0378 | Hospital observation service, per hour | <1% | 283 | $71K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,871 | $66K |
| 87275 | <1% | 6,535 | $61K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,783 | $58K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 12,337 | $56K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,501 | $54K |
| 80053 | Comprehensive metabolic panel | <1% | 8,835 | $53K |
| 87070 | <1% | 5,092 | $34K | |
| 81025 | <1% | 3,670 | $21K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 437 | $20K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,883 | $19K |
| 87641 | <1% | 974 | $18K | |
| 73560 | <1% | 571 | $18K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 92 | $16K |
| D2150 | Silver amalgam - two surfaces, primary or permanent | <1% | 53 | $14K |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,658 | $14K |
| 84484 | <1% | 2,326 | $14K | |
| 73630 | <1% | 350 | $14K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 166 | $14K |
| 81001 | <1% | 6,408 | $13K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,333 | $12K |
| 73610 | <1% | 215 | $10K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 97 | $9K |
| 87640 | <1% | 593 | $8K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 263 | $8K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 138 | $8K |
| D2140 | <1% | 33 | $8K | |
| 83690 | <1% | 1,623 | $7K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 357 | $7K |
| 72100 | <1% | 126 | $6K | |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 33 | $5K |
| 85610 | <1% | 2,358 | $5K | |
| 74018 | <1% | 124 | $4K | |
| 85730 | <1% | 1,595 | $4K | |
| 82962 | <1% | 2,203 | $4K | |
| 87077 | <1% | 726 | $4K | |
| 73130 | <1% | 69 | $3K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 85 | $2K |
| 83880 | <1% | 157 | $2K | |
| 87186 | <1% | 472 | $2K | |
| 73110 | <1% | 43 | $2K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 30 | $2K |
| 80061 | Lipid panel | <1% | 295 | $2K |
| 87420 | <1% | 173 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 193 | $2K |
| D0350 | <1% | 185 | $2K | |
| D2393 | Resin-based composite - three surfaces, posterior, primary or permanent | <1% | 14 | $2K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,775 | $2K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 74 | $1K |
| 73030 | <1% | 35 | $1K | |
| D0140 | Limited oral evaluation - problem focused | <1% | 187 | $726.70 |
| 82553 | <1% | 88 | $713.58 | |
| 97161 | <1% | 16 | $671.37 | |
| 82550 | <1% | 121 | $636.08 | |
| 81003 | <1% | 556 | $620.49 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 30 | $569.76 |
| 83874 | <1% | 55 | $552.11 | |
| 86900 | <1% | 16 | $525.88 | |
| 83735 | <1% | 147 | $524.44 | |
| 93971 | <1% | 14 | $437.58 | |
| 87040 | <1% | 30 | $418.84 | |
| D1351 | Sealant - per tooth | <1% | 13 | $370.75 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 947 | $319.69 |
| 87807 | <1% | 35 | $295.71 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,259 | $240.35 |
| 83605 | <1% | 51 | $208.90 | |
| 85027 | <1% | 46 | $191.67 | |
| 97116 | <1% | 20 | $183.38 | |
| 86901 | <1% | 16 | $158.96 | |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 60 | $137.18 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 45 | $125.45 |
| J2704 | Injection, propofol, 10 mg | <1% | 5,224 | $120.14 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 4,642 | $110.17 |
| 85378 | <1% | 15 | $105.27 | |
| 82150 | <1% | 13 | $93.88 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 107 | $72.88 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 1,252 | $67.75 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 3,452 | $40.75 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 6,964 | $28.90 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,368 | $28.89 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,163 | $26.11 |
| 85652 | <1% | 15 | $25.66 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 6,894 | $25.65 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,675 | $0.32 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 364 | $0.23 |
| J7510 | Prednisolone oral, per 5 mg | 0% | 32 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 1,469 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 409 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 53 | $0.00 |
| C1758 | Catheter, ureteral | 0% | 482 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 276 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 214 | $0.00 |
| 90714 | 0% | 77 | $0.00 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 84 | $0.00 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 0% | 238 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 35 | $0.00 |
| G1002 | Clinical decision support mechanism medcurrent, as defined by the medicare appropriate use criteria program | 0% | 65 | $0.00 |
| C1762 | Connective tissue, human (includes fascia lata) | 0% | 27 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 25 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 22 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 2,034 | $0.00 |
| J7121 | 5% dextrose in lactated ringers infusion, up to 1000 cc | 0% | 2,966 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 1,685 | $0.00 |
| 94760 | 0% | 202 | $0.00 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 14 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 81 | $0.00 |
| 96376 | 0% | 60 | $0.00 | |
| J3490 | Unclassified drugs | 0% | 90 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.